Boehringer Ingelheim working with The Christie NHS Foundation Trust

0 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
A Collaborative Working Project between Boehringer Ingelheim Limited and The Christie NHS Foundation Trust to establish a standardised diagnostic and treatment pathway that will enable systemic change for the benefit of patients with Large Cell Neuroendocrine of the Lung, (L-LCNEC).

The initial phase of the project is to establish an expert-led consensus that will outline the protocol to diagnose L-LCNEC and agree treatment guidelines, improving diagnosis timelines and standardise access to treatment.

The final phase of the project will be to enable data inclusion to the National Lung Cancer Audit database, subsequently providing improved understanding of treatment at a population level.
Category
Oncology
Be the first to comment

Up Next